Market Place
Sourcing Support
iCAD`s Proposed Acquisition by RadNet Backed by ISS, Glass Lewis
08 Jul 2025 //
GLOBENEWSWIRE
iCAD Reports Q1 2025 Financial Results
13 May 2025 //
GLOBENEWSWIRE
iCAD Appoints Mark Koeniguer as Chief Commercial Officer
08 Apr 2025 //
GLOBENEWSWIRE
iCAD Reports Q4 & Full-Year 2024 Financial Results
19 Mar 2025 //
GLOBENEWSWIRE
iCAD to Report Q4 and Full Year 2024 Results on March 19, 2025
11 Mar 2025 //
GLOBENEWSWIRE
iCAD Pre-Announces Estimated Q4 2024 Revenue
27 Jan 2025 //
GLOBENEWSWIRE
iCAD Advances Breast Cancer Fight with AI Solutions at RSNA 2024
04 Dec 2024 //
GLOBENEWSWIRE
iCAD Reports Financial Results for Q3 Ended September 30, 2024
13 Nov 2024 //
GLOBENEWSWIRE
iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference
06 Nov 2024 //
GLOBENEWSWIRE
iCAD to Report Q3 2024 Financial Results on Nov 13, 2024
05 Nov 2024 //
GLOBENEWSWIRE
iCAD Reports Financial Results for Second Quarter Ended June 30, 2024
13 Aug 2024 //
GLOBENEWSWIRE
iCAD to Report Second Quarter 2024 Financial Results on August 13, 2024
06 Aug 2024 //
GLOBENEWSWIRE
iCAD to Participate in the MedInvest MedTech, AI & Digital Health Conference
04 Jun 2024 //
GLOBENEWSWIRE
iCAD Reports Financial Results for First Quarter Ended March 31, 2024
15 May 2024 //
GLOBENEWSWIRE
UPDATE - iCAD to Report First Quarter 2024 Financial Results on May 15, 2024
08 May 2024 //
GLOBENEWSWIRE
iCAD to Report First Quarter 2024 Financial Results on May 15, 2024
02 May 2024 //
GLOBENEWSWIRE
iCAD, Densitas Partner for Enhanced Breast Health
09 Apr 2024 //
GLOBENEWSWIRE
iCAD`s AI Suite Uncovers Hidden Heart Disease Risk According to New Data
08 Apr 2024 //
GLOBENEWSWIRE
iCAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI
03 Apr 2024 //
GLOBENEWSWIRE
iCAD Unveils ProFound Cloud, Enabling Interoperability & Access to Breast AI Sol
02 Apr 2024 //
GLOBENEWSWIRE
iCAD Releases Enhanced ProFound Detection Workstation Features
19 Mar 2024 //
GLOBENEWSWIRE
iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results
12 Mar 2024 //
GLOBENEWSWIRE
iCAD Highlights Data Showing Ability to Reduce Breast Interval Cancer Rates
28 Feb 2024 //
GLOBENEWSWIRE
iCAD to Report Fourth Quarter and Full Year 2023 Financial Results
27 Feb 2024 //
GLOBENEWSWIRE
iCAD expands appointed Dr. Hedvig Hricak, MD, PhD, (Dr.h.cáµ)
27 Feb 2024 //
GLOBENEWSWIRE
iCAD to Participate in the BTIG at Snowbird
06 Feb 2024 //
GLOBENEWSWIRE
iCAD Expands Board of Directors with Appointment of Michael J. Doyle
30 Jan 2024 //
GLOBENEWSWIRE
iCAD Expands Executive Sales Leadership Team as Business Grows
18 Dec 2023 //
GLOBENEWSWIRE
iCAD`s AI-powered solutions to Help Accelerate Breast Cancer Detection
28 Nov 2023 //
GLOBENEWSWIRE
iCAD and CancerIQ Announce Partnership to Integrate AI-Enabled Technology
20 Nov 2023 //
GLOBENEWSWIRE
iCAD to Participate in the 14th Annual Craig-Hallum Alpha Select Conference
14 Nov 2023 //
GLOBENEWSWIRE
iCAD Reports Financial Results for Third Quarter Ended September 30, 2023
13 Nov 2023 //
GLOBENEWSWIRE
iCAD to Report Third Quarter 2023 Financial Results on November 13, 2023
30 Oct 2023 //
GLOBENEWSWIRE
iCAD, Inc. Announces Sale of Xoft, its Brachytherapy Business Line, to Elekta
23 Oct 2023 //
GLOBENEWSWIRE
Health Canada Grants Device License for iCAD`s ProFound Risk 2.0
16 Aug 2023 //
GLOBENEWSWIRE
iCAD and Google Health Expand Integration of Google™s AI Technology
14 Aug 2023 //
GLOBENEWSWIRE
iCAD Reports Financial Results for Second Quarter Ended June 30, 2023
14 Aug 2023 //
GLOBENEWSWIRE
iCAD to Report Second Quarter 2023 Financial Results on August 14, 2023
31 Jul 2023 //
GLOBENEWSWIRE
iCAD Signs Strategic Commercial Agreement with Radiology Partners
18 Jul 2023 //
GLOBENEWSWIRE
iCADs ProFound Insights, ProFound Impact Webinar Series to Feature Cleveland
12 Jul 2023 //
GLOBENEWSWIRE
iCAD Offers ROI Analysis Based on Results from its ProFound Breast AI Suite
10 Jul 2023 //
GLOBENEWSWIRE
iCAD Reports Financial Results for First Quarter Ended March 31, 2023
15 May 2023 //
GLOBENEWSWIRE
Long-Term Research Confirms Xoft Skin eBx is as Safe as Mohs Surgery
11 May 2023 //
GLOBENEWSWIRE
iCAD Showcases Breast AI Suite at Society of Breast Imaging Symposium, World
03 May 2023 //
GLOBENEWSWIRE
iCAD to Report First Quarter 2023 Financial Results on May 15, 2023
01 May 2023 //
GLOBENEWSWIRE
New and Real-World Clinical Confirms ProFound AI Increases Cancer Detection
20 Apr 2023 //
GLOBENEWSWIRE
iCAD Strengthens Leadership Team with Appointment of Chief Financial Officer
17 Apr 2023 //
GLOBENEWSWIRE
iCAD Reports Financial Results for Fourth Quarter ended December 31, 2022
28 Mar 2023 //
GLOBENEWSWIRE
Mammography AI maker iCad lays off 28% of workers
27 Mar 2023 //
FIERCE BIOTECH
iCAD Breast AI Suite Empowers Customers to Lead the Way in Support
23 Mar 2023 //
GLOBENEWSWIRE
iCAD Announces Leadership Transition
13 Mar 2023 //
GLOBENEWSWIRE
iCAD Previews Fourth Quarter Financial Results, Full Report on March 28, 2023
13 Mar 2023 //
GLOBENEWSWIRE
New Real-World Clinical Evidence Confirms ProFound AI Boosts
01 Mar 2023 //
GLOBENEWSWIRE
iCAD to Participate in the BTIG Snowbird MedTech, Digital Health Conference
09 Feb 2023 //
GLOBENEWSWIRE
iCAD Announces CFO Transition and Hires New Senior Vice President
23 Jan 2023 //
GLOBENEWSWIRE
iCAD Announces Board of Directors Transition
11 Jan 2023 //
GLOBENEWSWIRE
iCAD features Solis Mammography in upcoming “ProFound Insights, ProFound Impact”
08 Dec 2022 //
GLOBENEWSWIRE
iCAD and Google Health Ink Strategic Development and Commercialization Agreement
28 Nov 2022 //
GLOBENEWSWIRE
iCAD’s Breast AI Suite Improves Radiologists’ Performance and Cancer Detection
21 Nov 2022 //
GLOBENEWSWIRE
iCAD to Report Third Quarter 2022 Financial Results on November 10, 2022
27 Oct 2022 //
GLOBENEWSWIRE
